Cancer

October 25, 2012

Combined drug therapy may delay melanoma progression

Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene.

By VUMC News and Communications
October 23, 2012

Stomach bug alters tumor suppressor

The stomach bug Helicobacter pylori increases forms of a protein that promote tumor development, perhaps explaining how it elevates risk for gastric cancer.

By Leigh MacMillan
October 19, 2012

More gene links to breast cancer risk

Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.

By VUMC News and Communications
October 16, 2012

Volunteers needed for Race for the Cure and Healthy Living Expo

By VUMC News and Communications
October 16, 2012

Vanderbilt University Medical Center observes Breast Reconstruction Awareness (BRA) Day

By VUMC News and Communications
October 11, 2012

Netterville to lead otolaryngology-head, neck surgery group

James Netterville, M.D., professor of Otolaryngology and director of the Head and Neck Surgical Oncology Service, has been elected president of the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) and its foundation for the 2012-13 term. He assumed his position in September during the annual meeting in Washington, D.C.

By VUMC News and Communications
October 4, 2012

An orphan enzyme’s purpose

“Orphan” enzyme may play role in cancer growth, new research suggests.
By VUMC News and Communications
September 27, 2012

Photo: Lung Cancer Partnership

By VUMC News and Communications
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
By VUMC News and Communications
September 26, 2012

LifeFlight goes pink for breast cancer awareness

By VUMC News and Communications
September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
By VUMC News and Communications
September 20, 2012

Grant renewal boosts GI cancer research program

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI).
By VUMC News and Communications
September 13, 2012

Cells with LIP eat their neighbors

A transcription factor called LIP is capable of causing one cell to consume another.
By Leigh MacMillan
1 … 56 57 58 59 60 … 69